Header Logo

Connection

RADEK SKODA to Sympathomimetics

Back to Details
This is a "connection" page, showing publications RADEK SKODA has written about Sympathomimetics.
RADEK SKODA
Connection Strength
0.155
Sympathomimetics
  1. The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14. Haematologica. 2019 04; 104(4):710-716.
    View in: PubMed
    Score: 0.155
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.